Literature DB >> 24768927

Microbiota of Demodex mites from rosacea patients and controls.

Nathalia Murillo1, Jérome Aubert2, Didier Raoult3.   

Abstract

Proliferation of Demodex mites is associated with rosacea. Furthermore, Demodex-associated bacteria were suggested to play a role in the pathogenesis of rosacea. We decided to analyze Demodex microbiota. Mites were collected by standardized skin surface biopsies from patients with erythematotelangiectatic, papulopustular rosacea or from control subjects. The microbiota from each mite was characterized by 16S rRNA clone library approach. The 16S rRNA clone library consisted of 367 clones obtained from 73 extracts originating from 5 samples per study group (ETR, PPR or healthy subjects). A total of 86 species were identified with 36 as Demodex-specific microbiota. In the papulopustular group, proportions of Proteobacteria and Firmicutes increased whereas proportion of Actinobacteria decreased. Here, we report preliminary results on the microbiota of Demodex mites based on a molecular approach showing an unexpected diversity. Differences according to the host status need to be confirmed but open new perspectives for diagnostic of rosacea.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  16S; Clone library; Demodex; Microbiota; Mites; Rosacea

Mesh:

Substances:

Year:  2014        PMID: 24768927     DOI: 10.1016/j.micpath.2014.04.002

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  16 in total

1.  Prevalence of ocular demodicosis among patients at Tertiary Care Center, Bangkok, Thailand.

Authors:  Ngamjit Kasetsuwan; Kitchaporn Kositphipat; Mathu Busayarat; Pawanrat Threekhan; Kanok Preativatanyou; Atchara Phumee; Padet Siriyasatien
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

2.  Association study of Demodex bacteria and facial dermatoses based on DGGE technique.

Authors:  YaE Zhao; Fan Yang; RuiLing Wang; DongLing Niu; Xin Mu; Rui Yang; Li Hu
Journal:  Parasitol Res       Date:  2017-01-06       Impact factor: 2.289

Review 3.  Shaping of cutaneous function by encounters with commensals.

Authors:  Emma Barnard; Huiying Li
Journal:  J Physiol       Date:  2016-04-13       Impact factor: 5.182

4.  Activation of Neutrophils via IP3 Pathway Following Exposure to Demodex-Associated Bacterial Proteins.

Authors:  Fred McMahon; Nessa Banville; David A Bergin; Christian Smedman; Staffan Paulie; Emer Reeves; Kevin Kavanagh
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

Review 5.  Challenges in exploring and manipulating the human skin microbiome.

Authors:  Manon Boxberger; Valérie Cenizo; Nadim Cassir; Bernard La Scola
Journal:  Microbiome       Date:  2021-05-30       Impact factor: 14.650

Review 6.  Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction.

Authors:  Christophe Baudouin; Elisabeth M Messmer; Pasquale Aragona; Gerd Geerling; Yonca A Akova; José Benítez-del-Castillo; Kostas G Boboridis; Jesús Merayo-Lloves; Maurizio Rolando; Marc Labetoulle
Journal:  Br J Ophthalmol       Date:  2016-01-18       Impact factor: 4.638

7.  Efficacy of intra-meibomian gland injection of the anti-VEGF agent bevacizumab for the treatment of meibomian gland dysfunction with lid-margin vascularity.

Authors:  Xiaodan Jiang; Yuexin Wang; Huibin Lv; Yan Liu; Mingzhou Zhang; Xuemin Li
Journal:  Drug Des Devel Ther       Date:  2018-05-16       Impact factor: 4.162

Review 8.  Recent advances in understanding and managing rosacea.

Authors:  Joerg Buddenkotte; Martin Steinhoff
Journal:  F1000Res       Date:  2018-12-03

9.  Characterization and Analysis of the Skin Microbiota in Rosacea: Impact of Systemic Antibiotics.

Authors:  Yu Ri Woo; Se Hoon Lee; Sang Hyun Cho; Jeong Deuk Lee; Hei Sung Kim
Journal:  J Clin Med       Date:  2020-01-09       Impact factor: 4.241

10.  Characterization and Analysis of the Skin Microbiota in Acne: Impact of Systemic Antibiotics.

Authors:  Seo-Yeon Park; Hei Sung Kim; Se Hoon Lee; Sungjoo Kim
Journal:  J Clin Med       Date:  2020-01-08       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.